Last edition
News about Global Pharma
AIxMed and PathNet Partner to Advance Digital Pathology with AI-Driven Urine Cytology
AIxMed has partnered with PathNet to advance digital pathology through its AIxURO solution, an AI-powered platform designed to enhance the analysis of non-invasive urine cytology samples. The collaboration aims to boost diagnostic accuracy and streamline workflows in bladder cancer detection.
Global Pharma | 04/11/2025 | By Dineshwori | 313
US-based biotechnology company Kaigene has signed an exclusive global licensing agreement with South Korean biopharmaceutical giant Celltrion to develop and commercialise two of its nonclinical-stage antibody assets, KG006 and KG002.
Global Pharma | 04/11/2025 | By Dineshwori | 876
Akeso's Ivonescimab Wins 4th Breakthrough Therapy Nod in China for TNBC
Akeso has secured its fourth Breakthrough Therapy Designation (BTD) in China for Ivonescimab, targeting first-line treatment of triple-negative breast cancer (TNBC). The ongoing Phase III HARMONi-BC1 trial is assessing its safety and efficacy in this hard-to-treat cancer type.
Global Pharma | 03/11/2025 | By Dineshwori | 255
EU Approves KEYTRUDA for PD-L1+ Resectable Head and Neck Cancer
KEYTRUDA monotherapy has been approved for use as a neoadjuvant treatment, followed by adjuvant therapy in combination with radiotherapy with or without cisplatin, and continued thereafter as maintenance monotherapy.
Global Pharma | 30/10/2025 | By Dineshwori | 256
GSK Raises 2025 Outlook as Cancer and HIV Drug Sales Surge
Despite a significant fall in USA sales of its shingles vaccine, Shingrix, GSK shares climbed to their highest level since May 2024, rising as much as 4.3 per cent. The stock has already advanced about 25 per cent this year.
Global Pharma | 30/10/2025 | By Darshana | 345
Cambridge Isotope Laboratories (CIL), a subsidiary of Japan’s Otsuka Pharmaceutical, has signed a Memorandum of Understanding (MoU) with Hyderabad-based Chemtatva Chiral Solutions (CCS) to establish a new entity — Cambridge Isotope Laboratories Pvt. Ltd. — in Hyderabad, India.
Global Pharma | 29/10/2025 | By Dineshwori | 555
GHIT Fund Announces USD 11.6 Million to Boost R&D for TB, Leishmaniasis and Malaria
The Global Health Innovative Technology (GHIT) Fund, a Japan-based international public-private partnership (PPP), has announced a total investment of approximately USD 11.6 million to support four new research and development (R&D) projects targeting tuberculosis (TB), neglected tropical diseases (NTDs) and malaria.
Global Pharma | 29/10/2025 | By Dineshwori | 293
KP Group and Fabtech Group Partner to Build Green Infrastructure for Global Life Sciences Projects
Under the partnership, all projects executed by Fabtech Group—including conventional and stick-built—will be powered by clean, renewable energy supplied by KP Group.
Global Pharma | 28/10/2025 | By Dineshwori | 233
Lupin Expands US Footprint with New Corporate Offices in Bridgewater, New Jersey
Lupin has inaugurated its new corporate offices at 100 Somerset Corporate Blvd, Bridgewater, New Jersey, expanding its presence in the state where it already operates manufacturing and research facilities.
Global Pharma | 28/10/2025 | By Dineshwori | 360
Akums Expands Global Footprint with New Pharmaceutical Facility in Zambia
Akums Drugs & Pharmaceuticals has held the groundbreaking ceremony of its first overseas manufacturing facility in Zambia, marking a major milestone in its global expansion journey.
Global Pharma | 28/10/2025 | By Dineshwori | 309
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy